LP18787-9
Sulfonylurea
Active
Description
Sulfonylurea (UK: Sulphonylurea) derivatives are antidiabetic drugs primarily used to treat diabetes mellitus type 2, and include drugs such as Chlorpropamide, Tolazamide, Tolbutamide, Glyburide, Gliclazide, Glipizide, Gliquidone, Acetohexamide and others. They act by increasing insulin release from the beta cells in the pancreas. Sulfonylureas are ineffective where there is absolute deficiency of insulin production such as in type 1 diabetes or post-pancreatectomy. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Sulfonylureas
Basic Part Properties
- Part Display Name
- Sulfonylurea
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2000-05-04
- Construct for LOINC Short Name
- Sulfonylurea
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP18787-9 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP18787-9
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 磺酰脲类 Synonyms: 硫酰脲类降糖药; |
| fr-CA | French (Canada) | Sulfonylurée |
| et-EE | Estonian (Estonia) | Sulfonüüluurea |
| es-ES | Spanish (Spain) | Sulfonilureas |
| it-IT | Italian (Italy) | Sulfonilurea |
| tr-TR | Turkish (Turkey) | Sülfonilğre |
| ru-RU | Russian (Russian Federation) | Сульфонилмочевина |
| nl-NL | Dutch (Netherlands) | sulfonylureum |
| fr-BE | French (Belgium) | Sulfonylurée |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright